44 min
GM CEO, Pfizer CEO & Crowning New Dividend Aristocrats 1/31/23 Mad Money w/ Jim Cramer
-
- Investing
All three averages closed higher, reversing off yesterday's losses, and Jim Cramer is digging deeper into the turnaround. First, GM CEO Mary Barra stops by fresh off earnings to talk to Cramer about the quarter, the company's presence in the EV market and more. Then, Pfizer reported record 2022 revenue, but how might the winding down of the pandemic impact the company? Cramer's got CEO Albert Bourla to find out more about 4Q earnings and lower-than-expected guidance. Plus, Cramer crowns some new dividend aristocrats for investors to consider.
All three averages closed higher, reversing off yesterday's losses, and Jim Cramer is digging deeper into the turnaround. First, GM CEO Mary Barra stops by fresh off earnings to talk to Cramer about the quarter, the company's presence in the EV market and more. Then, Pfizer reported record 2022 revenue, but how might the winding down of the pandemic impact the company? Cramer's got CEO Albert Bourla to find out more about 4Q earnings and lower-than-expected guidance. Plus, Cramer crowns some new dividend aristocrats for investors to consider.
44 min